| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterococcus faecium | 20 | 2024 | 33 | 4.340 |
Why?
|
| Anti-Bacterial Agents | 13 | 2024 | 847 | 2.180 |
Why?
|
| Gram-Positive Bacterial Infections | 8 | 2024 | 52 | 1.880 |
Why?
|
| Bacterial Proteins | 21 | 2024 | 922 | 1.840 |
Why?
|
| Fimbriae, Bacterial | 9 | 2016 | 24 | 1.570 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 7 | 2024 | 52 | 1.260 |
Why?
|
| Cross Infection | 8 | 2024 | 159 | 1.260 |
Why?
|
| Fimbriae Proteins | 6 | 2012 | 15 | 1.180 |
Why?
|
| beta-Lactamases | 6 | 2024 | 57 | 1.080 |
Why?
|
| Cephalosporins | 2 | 2018 | 25 | 1.020 |
Why?
|
| Biofilms | 9 | 2017 | 50 | 1.000 |
Why?
|
| Microbial Sensitivity Tests | 8 | 2024 | 153 | 0.990 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2023 | 42 | 0.880 |
Why?
|
| Enterococcus | 2 | 2017 | 35 | 0.810 |
Why?
|
| Bacteroides | 1 | 2023 | 35 | 0.810 |
Why?
|
| Teichoic Acids | 4 | 2017 | 18 | 0.800 |
Why?
|
| Intestinal Mucosa | 3 | 2018 | 825 | 0.740 |
Why?
|
| Lipopolysaccharides | 4 | 2017 | 305 | 0.720 |
Why?
|
| Cell Wall | 6 | 2017 | 75 | 0.690 |
Why?
|
| Klebsiella Infections | 3 | 2024 | 32 | 0.620 |
Why?
|
| Klebsiella pneumoniae | 3 | 2024 | 41 | 0.620 |
Why?
|
| Immunity, Mucosal | 1 | 2018 | 72 | 0.540 |
Why?
|
| Biosynthetic Pathways | 1 | 2017 | 16 | 0.510 |
Why?
|
| Drug Synergism | 1 | 2017 | 317 | 0.490 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 96 | 0.480 |
Why?
|
| Bacillus cereus | 2 | 2012 | 10 | 0.470 |
Why?
|
| Gram-Positive Bacteria | 2 | 2013 | 20 | 0.440 |
Why?
|
| Dysbiosis | 1 | 2015 | 91 | 0.430 |
Why?
|
| Colon | 1 | 2018 | 542 | 0.430 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 84 | 0.400 |
Why?
|
| Adhesins, Bacterial | 2 | 2013 | 36 | 0.400 |
Why?
|
| Staphylococcus aureus | 5 | 2016 | 285 | 0.390 |
Why?
|
| Membrane Proteins | 7 | 2015 | 1275 | 0.390 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2024 | 200 | 0.380 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2015 | 220 | 0.370 |
Why?
|
| Staphylococcal Infections | 4 | 2023 | 289 | 0.350 |
Why?
|
| Aminoacyltransferases | 1 | 2011 | 10 | 0.340 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 90 | 0.330 |
Why?
|
| Enterococcus faecalis | 3 | 2017 | 57 | 0.310 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 65 | 0.310 |
Why?
|
| Bacterial Adhesion | 7 | 2016 | 85 | 0.310 |
Why?
|
| Virulence Factors | 5 | 2023 | 113 | 0.290 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2014 | 57 | 0.280 |
Why?
|
| Oxidoreductases | 1 | 2008 | 115 | 0.280 |
Why?
|
| Organoids | 2 | 2019 | 78 | 0.270 |
Why?
|
| Netherlands | 5 | 2024 | 25 | 0.270 |
Why?
|
| Nisin | 2 | 2017 | 4 | 0.250 |
Why?
|
| Mucus | 3 | 2016 | 19 | 0.230 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2015 | 138 | 0.230 |
Why?
|
| Humans | 31 | 2024 | 95798 | 0.220 |
Why?
|
| Multigene Family | 5 | 2023 | 213 | 0.220 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 3040 | 0.220 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2024 | 14 | 0.220 |
Why?
|
| Azabicyclo Compounds | 1 | 2024 | 4 | 0.220 |
Why?
|
| Ceftazidime | 1 | 2024 | 8 | 0.220 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 3 | 2013 | 11 | 0.210 |
Why?
|
| Agglutination | 2 | 2015 | 16 | 0.210 |
Why?
|
| Animals | 15 | 2019 | 28888 | 0.210 |
Why?
|
| Drug Combinations | 1 | 2024 | 213 | 0.210 |
Why?
|
| Phylogeny | 4 | 2024 | 1275 | 0.210 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 94 | 0.210 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 109 | 0.200 |
Why?
|
| Genome, Bacterial | 3 | 2010 | 159 | 0.200 |
Why?
|
| Infection Control | 1 | 2024 | 132 | 0.200 |
Why?
|
| Probiotics | 2 | 2016 | 92 | 0.200 |
Why?
|
| DNA, Bacterial | 4 | 2013 | 253 | 0.190 |
Why?
|
| Calcium | 2 | 2019 | 1205 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2019 | 590 | 0.190 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 85 | 0.180 |
Why?
|
| Temperature | 4 | 2015 | 426 | 0.180 |
Why?
|
| Membrane Glycoproteins | 3 | 2016 | 453 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 897 | 0.170 |
Why?
|
| Mice | 9 | 2019 | 12536 | 0.170 |
Why?
|
| Genomic Islands | 2 | 2011 | 14 | 0.170 |
Why?
|
| Sepsis | 3 | 2015 | 389 | 0.160 |
Why?
|
| Animal Feed | 1 | 2019 | 22 | 0.150 |
Why?
|
| Genes, Bacterial | 3 | 2012 | 199 | 0.150 |
Why?
|
| Feces | 3 | 2019 | 360 | 0.150 |
Why?
|
| Peritoneum | 1 | 2019 | 55 | 0.150 |
Why?
|
| Peritoneal Dialysis | 1 | 2019 | 31 | 0.150 |
Why?
|
| Fibrinogen | 2 | 2016 | 52 | 0.150 |
Why?
|
| Peptidoglycan | 3 | 2015 | 31 | 0.150 |
Why?
|
| Abdominal Wall | 1 | 2019 | 32 | 0.150 |
Why?
|
| Gastrectomy | 1 | 2019 | 70 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 71 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2019 | 133 | 0.140 |
Why?
|
| Cryptosporidium | 1 | 2018 | 4 | 0.140 |
Why?
|
| Cryptosporidiosis | 1 | 2018 | 6 | 0.140 |
Why?
|
| Gastric Bypass | 1 | 2019 | 114 | 0.140 |
Why?
|
| Penis | 1 | 2018 | 65 | 0.140 |
Why?
|
| Urethra | 1 | 2018 | 115 | 0.130 |
Why?
|
| Depsipeptides | 1 | 2017 | 32 | 0.130 |
Why?
|
| Microbial Interactions | 1 | 2016 | 12 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 180 | 0.120 |
Why?
|
| Staphylococcal Vaccines | 1 | 2016 | 17 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2013 | 796 | 0.120 |
Why?
|
| Vancomycin | 1 | 2017 | 75 | 0.120 |
Why?
|
| Osteomyelitis | 1 | 2016 | 57 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2016 | 106 | 0.120 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.120 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2015 | 18 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2017 | 118 | 0.120 |
Why?
|
| Models, Animal | 1 | 2017 | 286 | 0.120 |
Why?
|
| Uridine Diphosphate N-Acetylmuramic Acid | 1 | 2015 | 1 | 0.120 |
Why?
|
| Microscopy, Atomic Force | 2 | 2013 | 53 | 0.120 |
Why?
|
| Lipopeptides | 1 | 2015 | 20 | 0.110 |
Why?
|
| Fibronectins | 1 | 2015 | 100 | 0.110 |
Why?
|
| Prophages | 1 | 2015 | 3 | 0.110 |
Why?
|
| Virus Release | 1 | 2015 | 6 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2015 | 154 | 0.110 |
Why?
|
| Ukraine | 2 | 2024 | 22 | 0.110 |
Why?
|
| Multilocus Sequence Typing | 2 | 2024 | 13 | 0.110 |
Why?
|
| Quorum Sensing | 1 | 2015 | 28 | 0.110 |
Why?
|
| Virulence | 3 | 2011 | 279 | 0.110 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 39 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2019 | 454 | 0.110 |
Why?
|
| Cadherins | 1 | 2015 | 179 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2018 | 464 | 0.110 |
Why?
|
| Protein Multimerization | 2 | 2012 | 196 | 0.110 |
Why?
|
| Ctenocephalides | 1 | 2014 | 1 | 0.110 |
Why?
|
| Yersinia pestis | 1 | 2014 | 24 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2017 | 687 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2008 | 2089 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 750 | 0.100 |
Why?
|
| Hospitals | 2 | 2024 | 329 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2013 | 266 | 0.100 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2013 | 34 | 0.100 |
Why?
|
| Bacillaceae Infections | 1 | 2012 | 1 | 0.100 |
Why?
|
| Intestines | 1 | 2015 | 432 | 0.090 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2012 | 12 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 69 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1030 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1535 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 1087 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 91 | 0.090 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 74 | 0.090 |
Why?
|
| Collagen | 2 | 2013 | 306 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2012 | 126 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 170 | 0.090 |
Why?
|
| Mammals | 1 | 2013 | 261 | 0.090 |
Why?
|
| Protein Sorting Signals | 1 | 2011 | 42 | 0.080 |
Why?
|
| Bacterial Vaccines | 1 | 2011 | 45 | 0.080 |
Why?
|
| Elapid Venoms | 1 | 2010 | 5 | 0.080 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 12 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2010 | 329 | 0.080 |
Why?
|
| Microbiota | 1 | 2015 | 426 | 0.080 |
Why?
|
| RNA, Bacterial | 2 | 2007 | 112 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 655 | 0.080 |
Why?
|
| Blotting, Southern | 1 | 2009 | 126 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 183 | 0.080 |
Why?
|
| Gene Expression | 2 | 2013 | 1319 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 2090 | 0.070 |
Why?
|
| Ampicillin Resistance | 1 | 2009 | 5 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 28 | 0.070 |
Why?
|
| Dog Diseases | 1 | 2009 | 37 | 0.070 |
Why?
|
| Carrier State | 1 | 2009 | 40 | 0.070 |
Why?
|
| Disease Reservoirs | 1 | 2009 | 23 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 2605 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 380 | 0.070 |
Why?
|
| Crystallography, X-Ray | 3 | 2016 | 527 | 0.070 |
Why?
|
| Open Reading Frames | 1 | 2007 | 124 | 0.070 |
Why?
|
| Female | 7 | 2024 | 49868 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2015 | 1124 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 1730 | 0.060 |
Why?
|
| Proteolysis | 2 | 2016 | 124 | 0.060 |
Why?
|
| Kenya | 1 | 2024 | 9 | 0.050 |
Why?
|
| Enterobacteriaceae | 1 | 2024 | 22 | 0.050 |
Why?
|
| Protein Binding | 3 | 2015 | 1560 | 0.050 |
Why?
|
| Acinetobacter baumannii | 1 | 2024 | 29 | 0.050 |
Why?
|
| Health Facilities | 1 | 2024 | 41 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 340 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2024 | 157 | 0.050 |
Why?
|
| Male | 6 | 2024 | 45685 | 0.050 |
Why?
|
| Spain | 1 | 2023 | 35 | 0.050 |
Why?
|
| Genomics | 1 | 2009 | 857 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2023 | 20 | 0.050 |
Why?
|
| Binding Sites | 2 | 2016 | 1167 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 2 | 2014 | 116 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2024 | 245 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2012 | 488 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2013 | 29 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2012 | 358 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2007 | 1422 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2013 | 648 | 0.040 |
Why?
|
| Base Sequence | 2 | 2015 | 2342 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2016 | 1375 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 84 | 0.040 |
Why?
|
| Cadaver | 1 | 2019 | 204 | 0.040 |
Why?
|
| Cetuximab | 1 | 2019 | 119 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 215 | 0.040 |
Why?
|
| Species Specificity | 2 | 2011 | 707 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 259 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 279 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 26 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 128 | 0.030 |
Why?
|
| Carboplatin | 1 | 2019 | 328 | 0.030 |
Why?
|
| Weight Loss | 1 | 2019 | 240 | 0.030 |
Why?
|
| Models, Biological | 2 | 2018 | 1809 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2024 | 3970 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 528 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2011 | 726 | 0.030 |
Why?
|
| Biodiversity | 1 | 2019 | 238 | 0.030 |
Why?
|
| Cisplatin | 1 | 2019 | 599 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2016 | 12 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 490 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 747 | 0.030 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 207 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 327 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 259 | 0.030 |
Why?
|
| Mutation | 3 | 2013 | 4374 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2859 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2018 | 310 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 106 | 0.030 |
Why?
|
| Laminin | 1 | 2016 | 92 | 0.030 |
Why?
|
| Tryptophan | 1 | 2016 | 105 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2016 | 138 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2015 | 175 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 540 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 910 | 0.030 |
Why?
|
| Unilamellar Liposomes | 1 | 2015 | 5 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 422 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 164 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1208 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 50 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 25 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2534 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 478 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 125 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 28206 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 309 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 481 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 295 | 0.030 |
Why?
|
| Phosphatidylglycerols | 1 | 2013 | 5 | 0.020 |
Why?
|
| Child | 1 | 2024 | 7618 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 983 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 72 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2013 | 71 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 85 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 179 | 0.020 |
Why?
|
| Bacterial Capsules | 1 | 2012 | 29 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2013 | 165 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2013 | 53 | 0.020 |
Why?
|
| Crystallization | 1 | 2013 | 216 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2012 | 18 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 996 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2012 | 34 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 435 | 0.020 |
Why?
|
| Coagulants | 1 | 2011 | 7 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 108 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 197 | 0.020 |
Why?
|
| Antithrombins | 1 | 2011 | 18 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 40 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 75 | 0.020 |
Why?
|
| Coagulase | 1 | 2011 | 29 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 223 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 1380 | 0.020 |
Why?
|
| Longevity | 1 | 2011 | 60 | 0.020 |
Why?
|
| Conjugation, Genetic | 1 | 2011 | 22 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 439 | 0.020 |
Why?
|
| Bacillus megaterium | 1 | 2010 | 1 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 118 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 104 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 156 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 128 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 163 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 205 | 0.020 |
Why?
|
| Bacteriophages | 1 | 2010 | 54 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2061 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 311 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 187 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 28578 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 241 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1540 | 0.020 |
Why?
|
| Computational Biology | 1 | 2013 | 586 | 0.020 |
Why?
|
| Denmark | 1 | 2009 | 19 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 18 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 279 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 4154 | 0.020 |
Why?
|
| United Kingdom | 1 | 2009 | 192 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 592 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 590 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 681 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 718 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 935 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1827 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2006 | 22 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2006 | 22 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 236 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2011 | 984 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 3490 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1176 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 2575 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 1880 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 1878 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 20848 | 0.010 |
Why?
|